Missing Information refers to gaps in the knowledge and data available about a medicinal product. These gaps can pertain to various aspects of the product, including its safety profile, efficacy, or use in specific patient populations. Such gaps in information may be clinically significant because they can hinder a comprehensive understanding of the medication and its potential effects. Addressing missing information is crucial for ensuring informed decision-making in healthcare and pharmaceutical contexts.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management